| scholarly article | Q13442814 |
| P2093 | author name string | Rajinder Singh | |
| Wei Li | |||
| John McLaughlin | |||
| Annabelle M Friera | |||
| Donald G Payan | |||
| Guillermo Godinez | |||
| Ira J Smith | |||
| Kathy White | |||
| Kristen A Baltgalvis | |||
| Mark D Claypool | |||
| Todd M Kinsella | |||
| Wayne Lang | |||
| Tarikere Gururaja | |||
| Yasumichi Hitoshi | |||
| Dane Goff | |||
| David Lau | |||
| Baljit K Singh | |||
| Derek Hansen | |||
| Gary Park | |||
| Henry Nguyen | |||
| Simon J Shaw | |||
| Alison Pan | |||
| Gerald Uy | |||
| Kelly McCaughey | |||
| Raniel Alcantara | |||
| Tian-Qiang Sun | |||
| Vadim Markovtsov | |||
| Yingwu Li | |||
| Yonchu Jenkins | |||
| P2860 | cites work | Exercise for intermittent claudication | Q24241201 |
| A volumetric method for quantifying atherosclerosis in mice by using microCT: comparison to en face | Q27347208 | ||
| Peripheral arterial disease detection, awareness, and treatment in primary care | Q28216456 | ||
| High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria | Q28479257 | ||
| Optimization of microCT imaging and blood vessel diameter quantitation of preclinical specimen vasculature with radiopaque polymer injection medium | Q28740941 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Limb stress-rest perfusion imaging with contrast ultrasound for the assessment of peripheral arterial disease severity | Q30439764 | ||
| In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia | Q33275911 | ||
| Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo | Q33841044 | ||
| AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function | Q33848040 | ||
| Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction | Q33884283 | ||
| Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle | Q33905083 | ||
| Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion | Q34018743 | ||
| Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle | Q34085463 | ||
| Dietary obesity in nine inbred mouse strains | Q34458771 | ||
| Obesity impairs skeletal muscle AMPK signaling during exercise: role of AMPKα2 in the regulation of exercise capacity in vivo | Q34629476 | ||
| The pharmacology of cilostazol | Q34785781 | ||
| Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. | Q35090446 | ||
| Hypercholesterolemia impairs exercise capacity in mice | Q35117350 | ||
| Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues | Q35120340 | ||
| Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. | Q35120401 | ||
| AMP-activated protein kinase: a key system mediating metabolic responses to exercise | Q35621209 | ||
| Role of endothelial dysfunction in atherosclerosis | Q35806066 | ||
| Optimal exercise program length for patients with claudication | Q35923323 | ||
| Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion | Q36023067 | ||
| Peripheral arterial disease in patients with diabetes | Q36413265 | ||
| Adaptations of mouse skeletal muscle to low-intensity vibration training. | Q36778101 | ||
| Peripheral artery disease is associated with severe impairment of vascular function | Q36959476 | ||
| The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction | Q37048102 | ||
| Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease | Q37358898 | ||
| Muscle mitohormesis promotes longevity via systemic repression of insulin signaling | Q37377087 | ||
| Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype | Q37419996 | ||
| The effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials. | Q37740104 | ||
| Protective effects of AMP‐activated protein kinase in the cardiovascular system | Q37793322 | ||
| Arterial dysfunction and functional performance in patients with peripheral artery disease: a review | Q37859157 | ||
| Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success | Q38087578 | ||
| Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study | Q39472279 | ||
| Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication | Q39496701 | ||
| Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease | Q40821246 | ||
| Chronic changes in skeletal muscle histology and function in peripheral arterial disease | Q41090368 | ||
| Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training | Q41645356 | ||
| Sustained activation of AMPK ameliorates age-associated vascular endothelial dysfunction via a nitric oxide-independent mechanism | Q41985600 | ||
| Transthoracic echocardiography in mice | Q42124290 | ||
| Nitric oxide manipulation: a therapeutic target for peripheral arterial disease? | Q42558196 | ||
| Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription | Q42803087 | ||
| Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion | Q43132682 | ||
| The prevalence of peripheral arterial disease in a defined population | Q43564702 | ||
| AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise | Q43596055 | ||
| Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols | Q43774127 | ||
| Antithrombotic activity of AT-1015, a potent 5-HT(2A) receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time | Q43832379 | ||
| Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. | Q44059065 | ||
| Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
| AT-1015, a novel serotonin2A receptor antagonist, improves resaturation of exercised ischemic muscle in hypercholesterolemic rabbits | Q44775101 | ||
| Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy | Q44961036 | ||
| Diet-induced type II diabetes in C57BL/6J mice | Q45730735 | ||
| AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. | Q46037787 | ||
| Evaluating the glucose tolerance test in mice | Q46350758 | ||
| Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes | Q46680292 | ||
| Regional heterogeneity of functional changes in conduit arteries after high-fat diet | Q46779287 | ||
| Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase | Q46917092 | ||
| Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients. | Q53485665 | ||
| Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study. | Q53751960 | ||
| Determinants of peripheral arterial disease in the elderly: the Rotterdam study. | Q54195793 | ||
| Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease | Q58421063 | ||
| The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease | Q67922338 | ||
| Exercise training improves functional status in patients with peripheral arterial disease | Q70892839 | ||
| AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats | Q73697435 | ||
| Altered gait profile in subjects with peripheral arterial disease | Q73892805 | ||
| AMP-activated protein kinase phosphorylation of endothelial NO synthase | Q74456171 | ||
| Dimensions of blood vessels from distributing artery to collecting vein | Q76404751 | ||
| Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996 | Q78085319 | ||
| Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease | Q78117936 | ||
| Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease | Q78171879 | ||
| The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease | Q79674330 | ||
| Mitochondrial defects and oxidative damage in patients with peripheral arterial disease | Q79823960 | ||
| P433 | issue | 8 | |
| P304 | page(s) | H1128-45 | |
| P577 | publication date | 2014-02-21 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice | |
| P478 | volume | 306 |
| Q38773739 | A novel complex I inhibitor protects against hypertension-induced left ventricular hypertrophy |
| Q60920958 | A systematic comparison of exercise training protocols on animal models of cardiovascular capacity |
| Q92342120 | AMP-activated protein kinase: the current landscape for drug development |
| Q38549546 | Activation of AMPK and its Impact on Exercise Capacity |
| Q30383901 | Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain. |
| Q26740006 | An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus |
| Q50625174 | An association study between epicardial fat thickness and cognitive impairment in the elderly. |
| Q33885504 | Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease |
| Q89900560 | Development of a two-stage limb ischemia model to better simulate human peripheral artery disease |
| Q92642403 | Development of an Exercise Training Protocol to Investigate Arteriogenesis in a Murine Model of Peripheral Artery Disease |
| Q35275058 | Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways |
| Q27009178 | Imaging of small animal peripheral artery disease models: recent advancements and translational potential |
| Q89638544 | Imaging the Landmarks of Vascular Recovery |
| Q36339217 | Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox |
| Q51760150 | Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging. |
| Q38997492 | Mitochondria as targets of drug toxicity: Lessons from the R118 phase I experience |
| Q35817831 | Modulation of endothelial cell phenotype by physical activity: impact on obesity-related endothelial dysfunction |
| Q30279209 | PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease |
| Q89170110 | PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients |
| Q35224775 | Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases |
| Q47684621 | Toxicity of a novel therapeutic agent targeting mitochondrial complex I. |
| Q38419222 | Vascular AMPK as an attractive target in the treatment of vascular complications of obesity. |
Search more.